New digital twin technology that allows a University of Virginia-developed artificial pancreas system to adapt to users’ changing needs – and lets users adjust the settings – has been shown to improve ...

People from deprived and minority ethnic backgrounds have better access to device than for previous technologies ...

An artificial pancreas has long been considered the holy grail for people with Type 1 diabetes, and new research suggests a more convenient version of this technology may help the millions of people ...

A Canadian research team is examining the use of pramlintide in conjunction with insulin on the artificial-pancreas platform, with the goal of further improving blood glucose management for type 1 ...

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review ...

Researchers design a novel algorithm for controlling implanted insulin pumps that accounts for the unique characteristics of individual patients. Their model, tested using an FDA-approved diabetes ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The CamAPS FX links compatible CGMs and insulin pumps ...

When used in an appropriately trained and equipped clinic setting, supported open-source artificial pancreas systems (SOSAPS) are at least as safe and effective as retail APS, but with lower cost. An ...

An artificial pancreas improves blood sugar control in children ages 2 to 6 with type 1 diabetes, according to a new study. An artificial pancreas originally developed at the University of Virginia ...

Please provide your email address to receive an email when new articles are posted on . The FDA has authorized CamAPS FX, a closed loop algorithm that links compatible continuous glucose monitors and ...

Cambridge scientists have successfully trialled an artificial pancreas for use by patients living with type 2 diabetes. The device – powered by an algorithm developed at the University of Cambridge – ...